Crystallization (Comment) | Organism |
---|---|
molecular modeling of complex with inhibitor 3'-O-(2R)-1-(methylamino-1-oxopropan-2-yl)-tunicamycin V, the compound generates a steric clash between the N-methylpropanamide moiety introduced in the place of the GlcNAc moiety of 2 and loop E | Enterocloster bolteae |
molecular modeling of complex with inhibitor 3'-O-(2R)-1-(methylamino-1-oxopropan-2-yl)-tunicamycin V, the compound generates a steric clash between the N-methylpropanamide moiety introduced in the place of the GlcNAc moiety of 2 and loop E | Staphylococcus aureus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3'-O-(2R)-1-(methylamino-1-oxopropan-2-yl)-tunicamycin V | MurNAc analogue of tunicamycin. The inhibitor does not show toxicity against HepG2 cells up to 100 microM, and is a non-toxic selective MraY inhibitor | Enterocloster bolteae | |
3'-O-(2R)-1-(methylamino-1-oxopropan-2-yl)-tunicamycin V | MurNAc analogue of tunicamycin. The inhibitordoes not show toxicity against HepG2 cells up to 100 microM, and is a non-toxic selective MraY inhibitor.The inhibitor retains weak antibacterial activity against Staphylococcus aureus, the MIC value is reduced compared to tunicamycin | Staphylococcus aureus | |
tunicamycin V | - |
Enterocloster bolteae | |
tunicamycin V | - |
Staphylococcus aureus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Enterocloster bolteae | R0BTE9 | - |
- |
Enterocloster bolteae 90A9 | R0BTE9 | - |
- |
Staphylococcus aureus | R0BTE9 | - |
- |
Staphylococcus aureus ATCC 25923 | R0BTE9 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
MraY | - |
Enterocloster bolteae |
MraY | - |
Staphylococcus aureus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000087 | - |
pH 7.6, 23°C | Staphylococcus aureus | 3'-O-(2R)-1-(methylamino-1-oxopropan-2-yl)-tunicamycin V | |
0.00025 | - |
pH 7.6, 23°C | Staphylococcus aureus | tunicamycin V |